Table 4. Cox proportional hazard model for composite outcome of LTFU/death in EPTB patients (with or without pulmonary manifestation).

	Univariable		Multivariable
	HR (95% CI)	p	HR (95% CI)	p
Female sex a	0.86 (0.52, 1.41)	0.541	0.86 (0.52, 1.41)	0.541
CD4+ cell count at baseline [cells/ul)
<200	Reference		Reference
≥200	0.87 (0.53, 1.42)	0.59	0.94 (0.56, 1.58)	0.829
WHO stage at baseline
I & II	Reference		Reference
III & IV	1.10 (0.62, 1.97)	0.743	0.88 (0.46, 1.67)	0.693
Tuberculous meningitis b	0.91 (0.44, 1.89)	0.805	0.71 (0.33, 1.50)	0.363
ART intake c	0.19 (0.11, 0.32)	<0.001	0.15 (0.08, 0.27)	<0.001
Age > 45 years d	1.35 (0.84, 2.16)	0.214	1.95 (1.15, 3.30)	0.013

ART, antiretroviral therapy; CI, confidence intervall; HR, hazard ratio; LTFU, lost to follow-up; WHO world health organization

Reference groups:

^a male sex,

^b no tuberculous meningitis,

^c no ART intake,

^d age ≤ 45 years